SOX2 and neoplasm: Furthermore, we found that the DsRed+ (Sox2+) cells acquired chemoresistance to 5-FU and oxaliplatin, and that Sox2+ cells exhibited slower growth activity in vitro, though they exhibited larger tumor formation in vivo.